Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Tumor cells that survive oncogenic pathway inhibition exhibit cellular dormancy

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE60611 | GEO | 2020/07/24

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Tumor cells that survive oncogenic pathway inhibition exhibit cellular dormancy

Project description:Tumor cells that survive oncogenic pathway inhibition exhibit cellular dormancy

| PRJNA258647 | ENA

Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway

Project description:This SuperSeries is composed of the SubSeries listed below.

2020-01-13 | GSE131604 | GEO

Cancer cells enter an adaptive persistence to survive radiotherapy and repopulate tumor

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-01-06 | GSE221181 | GEO

Targeting Myc signaling pathway by inhibition of histone demethylase JMJD2B

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2014-01-01 | E-GEOD-45970 | biostudies-arrayexpress

Targeting of Super-Enhancer-Associated Oncogenic Transcription in MYCN-driven tumor cells by CDK7 inhibition

Project description:This SuperSeries is composed of the SubSeries listed below.

2014-11-21 | GSE62726 | GEO

INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2016-07-07 | E-GEOD-82334 | biostudies-arrayexpress

Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2013-03-07 | E-GEOD-44931 | biostudies-arrayexpress

Autocrine IGF1 Signaling Mediates Pancreatic Tumor Cell Dormancy in the Absence of Oncogenic Drivers.

Project description:Mutant KRAS and c-MYC are oncogenic drivers and rational therapeutic targets for the treatment of pancreatic cancer. Although tumor growth and homeostasis are largely dependent on these oncogenes, a few residual cancer cells are able to survive the ablation of mutant KRAS and c-MYC. By performing a genome-wide gene expression analysis of in vivo-derived bulk tumor cells and residual cancer cells lacking the expression of mutant KRAS or c-MYC, we have identified an increase in autocrine IGF1/AKT signaling as a common survival mechanism in dormant cancer cells. The pharmacological inhibition of IGF-1R reduces residual disease burden and cancer recurrence, suggesting that this molecular pathway is crucial for the survival of cancer cells in the absence of the primary oncogenic drivers.

| S-EPMC5369772 | biostudies-literature

Tumor cell dormancy.

Project description:Metastasis is the primary cause of death in cancer patients and current treatments fail to provide durable responses. Efforts to treat metastatic disease are hindered by the fact that metastatic cells often remain dormant for prolonged intervals of years, or even decades. Tumor dormancy reflects the capability of disseminated tumor cells (DTCs), or micrometastases, to evade treatment and remain at low numbers after primary tumor resection. Unfortunately, dormant cells will eventually produce overt metastasis. Innovations are needed to understand metastatic dormancy and improve cancer detection and treatment. Currently, few models exist that faithfully recapitulate metastatic dormancy and metastasis to clinically relevant tissues, such as the bone. Herein, we discuss recent advances describing genetic cell-autonomous and systemic or local changes in the microenvironment that have been shown to endow DTCs with properties to survive and eventually colonize distant organs.

| S-EPMC5423221 | biostudies-other

Novel synthetic ecteinascidins exhibit potent anti-melanoma activity by targeting super-enhancer-driven oncogenic transcription

Project description:This SuperSeries is composed of the SubSeries listed below. Note that Comp = PM54.

2024-02-23 | GSE256103 | GEO